Graphene is Asia’s fastest growing Decision science company. Founded in 2014, our fundamental mission is to disrupt traditional market research using artificial intelligence. With a focus on Pharma and Healthcare, FMCG & Banking, and a leadership team made up of technology, domain and business experts, Graphene brings to its engagements a practitioner’s perspective and depth of industry insight. With offices in India, Singapore and the US, Graphene has delivered solutions across the globe. Graphene uses AI-empowered market research to provide unbiased insights faster and cheaper. Built by domain experts in Pharma and Healthcare it supports 5 of the top 10 global pharma companies across 26 countries. Graphene AI helps companies reduce time to market and significantly enhance engagement with key stakeholders including consumers, doctors, patients and caregivers. From awareness and sentiment, to perception and behavior, it provides actionable insights that helps companies address the challenges in pharma & healthcare (diagnosis, treatment and infrastructure) and FMCG (brand equity, campaign effectiveness) so that companies can better support patients/consumers. Graphene provides insights in 55 different languages using a wide variety of sources that are relevant to respective domains (Pharma & Healthcare and FMCG).